QScript under review

As members are most likely aware, QScript (real-time prescription monitoring system) went live at the end of September 2021.

In response to ongoing advocacy by AMA Queensland and ASMOFQ, Queensland Health have confirmed that in early 2022, they will commence the review of the current regulations that govern the use of QScript. We recognise the important role that QScript is intended to play in minimising harm from dangerous medicines and we are aware that there has already been potential harm avoided to many patients as a result of the program.

We will keep members informed.